220 related articles for article (PubMed ID: 36334723)
1. Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.
Prabhu M; Yang YJ; Johnston CD; Murphy EA; Ketas TJ; Diaz-Tapia R; Jurkiewicz M; Racine-Brzostek S; Mohammed I; Sukhu AC; Singh S; Forlenza K; Iyer S; Yee J; Eng D; Marks K; Zhao Z; Klasse PJ; Permar S; Moore JP; Riley LE
Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100796. PubMed ID: 36334723
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.
Atyeo C; Shook LL; Nziza N; Deriso EA; Muir C; Baez AM; Lima RS; Demidkin S; Brigida S; De Guzman RM; Burns MD; Balazs AB; Fasano A; Yonker LM; Gray KJ; Alter G; Edlow AG
Am J Obstet Gynecol; 2023 Jan; 228(1):68.e1-68.e12. PubMed ID: 35868417
[TBL] [Abstract][Full Text] [Related]
3. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
[TBL] [Abstract][Full Text] [Related]
4. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
[TBL] [Abstract][Full Text] [Related]
5. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
[TBL] [Abstract][Full Text] [Related]
6. Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth.
Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Lahav Sher M; Barsha H; Shalabna E; Zolotarevsky A; Lavie O; Kedar R; Riskin-Mashiah S
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():148-154. PubMed ID: 35653903
[TBL] [Abstract][Full Text] [Related]
7. Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study.
Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
Clin Microbiol Infect; 2022 Mar; 28(3):419-425. PubMed ID: 34740773
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.
Cassidy AG; Li L; Golan Y; Gay C; Lin CY; Jigmeddagva U; Chidboy MA; Ilala M; Buarpung S; Gonzalez VJ; Basilio E; Duck M; Murtha AP; Wu AHB; Lynch KL; Asiodu IV; Prahl MK; Gaw SL
JAMA Netw Open; 2023 Jul; 6(7):e2323405. PubMed ID: 37450302
[TBL] [Abstract][Full Text] [Related]
10. Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born Preterm.
Kachikis A; Pike M; Eckert LO; Roberts E; Frank Y; Young AL; Goecker E; Gravett MG; Greninger AL; Englund JA
JAMA Netw Open; 2024 Jan; 7(1):e2352387. PubMed ID: 38241046
[TBL] [Abstract][Full Text] [Related]
11. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
Collier AY; McMahan K; Yu J; Tostanoski LH; Aguayo R; Ansel J; Chandrashekar A; Patel S; Apraku Bondzie E; Sellers D; Barrett J; Sanborn O; Wan H; Chang A; Anioke T; Nkolola J; Bradshaw C; Jacob-Dolan C; Feldman J; Gebre M; Borducchi EN; Liu J; Schmidt AG; Suscovich T; Linde C; Alter G; Hacker MR; Barouch DH
JAMA; 2021 Jun; 325(23):2370-2380. PubMed ID: 33983379
[TBL] [Abstract][Full Text] [Related]
13. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy.
Nir O; Schwartz A; Toussia-Cohen S; Leibovitch L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Lustig Y; Regev-Yochay G; Yinon Y
Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100492. PubMed ID: 34547533
[TBL] [Abstract][Full Text] [Related]
14. Maternal and Cord Anti-SARS-CoV-2-Spike IgG following COVID-19 Vaccination versus Infection during Pregnancy: A Prospective Study, Israel October 2021-March 2022.
Abu Shqara R; Frank Wolf M; Mikhail Mustafa S; Sgayer I; Assulyn T; Abu Zraki A; Askhar Majadla N; Rechnizter H; Shehadeh M; Fleisher Sheffer V; Bordeynik-Cohen M; Yakir O; Lowenstein L; Sela E; Edelstein M; Dror AA
Am J Perinatol; 2024 May; 41(S 01):e1935-e1943. PubMed ID: 37164317
[TBL] [Abstract][Full Text] [Related]
15. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.
Gray KJ; Bordt EA; Atyeo C; Deriso E; Akinwunmi B; Young N; Baez AM; Shook LL; Cvrk D; James K; De Guzman R; Brigida S; Diouf K; Goldfarb I; Bebell LM; Yonker LM; Fasano A; Rabi SA; Elovitz MA; Alter G; Edlow AG
Am J Obstet Gynecol; 2021 Sep; 225(3):303.e1-303.e17. PubMed ID: 33775692
[TBL] [Abstract][Full Text] [Related]
17. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
Scaggs Huang F
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels.
Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women.
Blakeway H; Amin-Chowdhury Z; Prasad S; Kalafat E; Ismail M; Abdallah FN; Rezvani A; Amirthalingam G; Brown K; Le Doare K; Heath PT; Ladhani SN; Khalil A
Ultrasound Obstet Gynecol; 2022 Nov; 60(5):673-680. PubMed ID: 36318630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
